Financial Performance in January-December 2021
Consolidated statement of comprehensive income, MEUR | 2021 |
2020 |
12 months | 12 months | |
Net sales | 86.9 | 78.4 |
Operating profit / loss | 3.2 | 2.1 |
Financial income and expenses | -0.7 | -0.4 |
Result before tax | 2.5 | 1.6 |
Result for the period | 3.3 | 2.2 |
Total comprehensive income for the period | 3.6 | 1.9 |
Result for the period attributable to: | ||
Equity holders of the parent | 3.3 | 2.2 |
Total comprehensive income for the period attributable to: | ||
Equity holders of the parent | 3.6 | 1.9 |
Earnings per share from continuing operations, EUR | 0.093 | 0.061 |
Half Year Figures
Group's net sales and operating result, MEUR | 2H/21 | 1H/21 | 2H/20 | 1H/20 |
Net sales | 47.2 | 39.7 | 35.8 | 42.5 |
Operating profit (loss) | 3.9 | -0.7 | -0.8 | 2.9 |
Result before taxes | 3.6 | -1.0 | -0.9 | 2.5 |
Result for the period | 4.4 | -1.0 | -0.4 | 2.5 |
Distribution of net sales by product and services, MEUR and % | 2H/21 | 1H/21 | 2H/20 | 1H/20 |
Product based netsales | 35.2 74.5% |
27.9 70.3% |
23.0 64.3% |
30.1 70.7% |
Services based net sales | 12.0 25.5% |
11.8 29.7% |
12.8 35.7% |
12.5 29.3% |
Distribution of product-based net sales, MEUR and % | 2H/21 | 1H/21 | 2H/20 | 1H/20 |
Defense & Security products | 20.8 59.3% |
14.5 51.8% |
15.1 65.5% |
20.6 68.6% |
Medical Technologies products | 14.3 40.7% |
13.5 48.2% |
8.0 34.5% |
9.5 31.4% |
Distribution of services-based net sales, MEUR and % | 2H/21 | 1H/21 | 2H/20 | 1H/20 |
Connectivity Solutions R&D services | 7.7 63.8% |
7.8 66.6% |
8.0 62.4% |
7.4 58.9% |
Other service-based net sales | 4.4 36.2% |
3.9 33.4% |
4.8 37.6% |
5.1 41.1% |
Distribution of net sales by market areas, MEUR and % | 2H/21 | 1/21 | 2H/20 | 1H/20 |
Asia | 0.3 0.6% |
0.3 0.6% |
0.2 0.5% |
0.2 0.4% |
Europe |
32.0 67.9% |
25.0 62.9% |
29.3 8.7% |
35.2 82.8% |
Americas |
14.9 31.5% |
14.4 36.4% |
6.4 17.8% |
7.1 16.7% |
Quarterly Figures
Group's net sales and operating result, MEUR | 4Q/21 | 3Q/21 | 2Q/21 | 1Q/21 | 4Q/20 |
Net sales | 30.1 | 17.1 | 22.6 | 17.0 | 21.8 |
Operating profit (loss) | 3.7 | 0.2 | 0.7 | -1,5 | 0.3 |
Result before taxes | 3.5 | 0.1 | 0.5 | -1.6 | 0.2 |
Result for the period | 4.3 | 0.1 | 0.5 | -1.6 | 0.7 |
Distribution of net sales by product and services, MEUR and % | 4Q/21 | 3Q/21 | 2Q/21 | 1Q/21 | 4Q/20 |
Product based net sales | 23.0 76.5% |
12.2 71.0% |
16.7 73.8% |
11.2 65.7% |
14.5 66.5% |
Services based net sales | 7.1 23.5% |
5.0 29.0% |
5.9 26.2% |
5.9 34.3% |
7.3 33.5% |
Distribution of product-based net sales, MEUR and % | 4Q/21 | 3Q/21 | 2Q/21 | 1Q/21 | 4Q/20 |
Defense & Security products | 15.5 67.6% |
5.3 43.4% |
11.2 66.8% |
3.3 29.5% |
10.7 73.6% |
Medical Technologies products | 7.4 32.4% |
6.9 56.6% |
5.6 33.2% |
7.9 70.5% |
3.8 26.4% |
Distribution of service-based net sales, MEUR and % | 4Q/21 | 3Q/21 | 2Q/21 | 1Q/21 | 4Q/20 |
Connectivity Solutions R&D services | 4.6 64.8% |
3.1 62.5% |
3.8 63.7% |
4.1 69.6% |
4.3 58.9% |
Other service-based net sales | 2.5 35.2% |
1.9 37.5% |
2.2 36.3% |
1.8 30.4% |
3.0 41.1% |
Distribution of net sales by market areas, MEUR and % | 4Q/21 | 3Q/21 | 2Q/21 | 1Q/21 | 4Q/20 |
Asia | 0.2 0.6% |
0.1 0.5% |
0.1 0.6% |
0.1 0.7% |
0.1 0.5% |
Europe |
21.1 70.2% |
10.9 63.8% |
15.3 67.5% |
9.7 56.9% |
18.8 86.2% |
Americas |
8.8 29.2% |
6.1 35.7% |
7.2 31.9% |
7.2 42.5% |
2.9 13.3% |
Unless otherwise mentioned, the figures in brackets refer to the corresponding period in the previous year.